Zacks Investment Research downgraded shares of Vitamin Shoppe (NYSE:VSI) from a strong-buy rating to a hold rating in a report released on Saturday, September 22nd.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

A number of other research analysts also recently commented on VSI. ValuEngine downgraded shares of Vitamin Shoppe from a hold rating to a sell rating in a report on Friday, June 1st. Barclays downgraded shares of Vitamin Shoppe from an equal weight rating to an underweight rating in a research note on Friday, September 7th. Finally, Morgan Stanley initiated coverage on shares of Vitamin Shoppe in a research note on Monday, September 17th. They issued an equal weight rating and a $14.00 price objective for the company.

Shares of VSI traded up $0.55 during midday trading on Friday, hitting $9.48. 871,600 shares of the company traded hands, compared to its average volume of 618,655. The company has a quick ratio of 0.32, a current ratio of 1.96 and a debt-to-equity ratio of 0.32. Vitamin Shoppe has a 52 week low of $2.95 and a 52 week high of $13.95. The company has a market capitalization of $240.53 million, a PE ratio of 24.31 and a beta of 0.76.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, August 8th. The specialty retailer reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.04 by $0.27. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%. The firm had revenue of $293.10 million during the quarter, compared to the consensus estimate of $279.87 million.

In other Vitamin Shoppe news, CEO Sharon M. Leite acquired 5,500 shares of the business’s stock in a transaction that occurred on Friday, August 31st. The shares were bought at an average cost of $12.64 per share, with a total value of $69,520.00. Following the completion of the acquisition, the chief executive officer now directly owns 5,500 shares in the company, valued at approximately $69,520. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Guillermo Marmol acquired 8,900 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The shares were acquired at an average cost of $11.21 per share, for a total transaction of $99,769.00. Following the completion of the acquisition, the director now owns 49,479 shares of the company’s stock, valued at $554,659.59. The disclosure for this purchase can be found here. Company insiders own 18.50% of the company’s stock.

A number of hedge funds have recently modified their holdings of VSI. GMT Capital Corp purchased a new position in Vitamin Shoppe during the second quarter valued at approximately $7,991,000. FMR LLC grew its holdings in Vitamin Shoppe by 49.7% in the second quarter. FMR LLC now owns 1,624,543 shares of the specialty retailer’s stock worth $11,290,000 after purchasing an additional 539,100 shares during the last quarter. Millennium Management LLC purchased a new position in Vitamin Shoppe in the first quarter worth $1,628,000. Schwab Charles Investment Management Inc. grew its holdings in Vitamin Shoppe by 29.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 863,237 shares of the specialty retailer’s stock worth $3,756,000 after purchasing an additional 196,125 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Vitamin Shoppe by 10.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock worth $7,288,000 after purchasing an additional 158,123 shares during the last quarter. 89.55% of the stock is currently owned by institutional investors.

About Vitamin Shoppe

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Read More: Book Value Per Share in Stock Trading

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.